News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact


Nicklas Westerholm, CEO

Yilmaz Mahshid, CFO


Calendar and upcoming reports

August 22, 2024
Interim Report Q2 2024 (7:00am CEST)

September 19, 2024
Pareto Annual Healthcare Conference

Show more events



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10